Canadian Post-SSRI

Sep 19, 2024 | link.springer.com | J. Andres |Simon Fraser |Canadian Post-SSRI |B.C. Association

AbstractPersistent post-treatment genital hypoesthesia (PPTGH) is a primary symptom of post-SSRI sexual dysfunction (PSSD), an iatrogenic syndrome characterized by enduring sexual dysfunction following the discontinuation of some antidepressants. We aimed to estimate the frequency of PPTGH among past users of psychiatric treatments, particularly antidepressants. We used a subsample of UnACoRN, a US/Canada survey of sexual and gender minority youth aged 15 to 29.